We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HPE:NYSEHewlett Packard Enterprise Company Analysis

Data as of 2026-03-10 - not real-time

$21.81

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

HPE is trading at $21.81, just below its DCF‑derived fair value of $21.96, implying a modest upside of roughly 19.5%. The stock benefits from a low forward P/E of 7.99 versus the industry average of 37.14, indicating it is undervalued. Revenue grew 18.4% YoY to $9.30 bn, and the company guided Q1 revenue to $9.8 bn, surpassing consensus. Although trailing profit margin is slightly negative, forward EPS of $2.73 signals a turnaround. Technicals show price above the 20‑day SMA (21.68) but below the 50‑day SMA (22.17), with a neutral RSI (50.4) and a bullish MACD histogram. Volume is increasing and the support level sits at $19.84, giving a comfortable cushion.
The dividend yield of 2.61% and a payout ratio of 61% are supported by strong operating cash flow of $4.49 bn. A beta of 1.63 and 30‑day volatility of 45% point to heightened market sensitivity. The recent launch of AI‑focused networking solutions at Mobile World Congress positions HPE to capture growth in the AI infrastructure market. Debt remains high at $21.6 bn, but cash of $4.84 bn and a debt‑to‑equity of 87% are manageable for a cash‑generating tech firm. Analyst consensus is a “Buy” with a median price target of $26, reinforcing the upside thesis. Overall, the combination of undervaluation, improving earnings outlook, and dividend income makes HPE an attractive near‑term play.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD histogram with increasing volume
  • Positive revenue guidance exceeding analyst expectations
  • Support level at $19.84 providing downside protection

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong AI‑focused product rollout expanding addressable market
  • Undervalued valuation relative to industry peers
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term tailwinds from AI infrastructure demand
  • Consistent cash flow generation supporting dividends and debt service
  • Margin of safety from DCF‑based fair value upside

Key Metrics & Analysis

Financial Health

Revenue Growth18.40%
Profit Margin-0.33%
P/E Ratio8.0
ROE-0.47%
ROA1.56%
Debt/Equity87.02
P/B Ratio1.2
Op. Cash Flow$4.5B
Free Cash Flow$1.6B
Industry P/E37.1

Technical Analysis

TrendNeutral
RSI50.4
Support$19.84
Resistance$24.38
MA 20$21.68
MA 50$22.17
MA 200$22.01
MACDBullish
VolumeIncreasing
Fear & Greed Index80.82

Valuation

Fair Value$21.96
Target Price$26.06
Upside/Downside19.52%
GradeUndervalued
TypeBlend
Dividend Yield2.61%

Risk Assessment

Beta1.63
Volatility45.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.